Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice
Author(s) -
Hao Pan,
Ngoc-Quynh-Nhu Nguyen,
Hiroshi Yoshida,
Frauke Bentzien,
Lynn C. Shaw,
Françoise RentierDelrue,
Joseph Martial,
Richard I. Weiner,
Ingrid Struman,
Maria B. Grant
Publication year - 2004
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.03-1001
Subject(s) - retinal , apoptosis , neovascularization , endocrinology , diabetic retinopathy , medicine , retina , biology , angiogenesis , ophthalmology , biochemistry , diabetes mellitus , neuroscience
To examine the ability and mechanism of the 16 kDa N-terminal fragment of human prolactin (16K hPRL) in the inhibition of abnormal retinal neovascularization.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom